Loading stocks --
Market News
English اردو

Citi Pharma Secures CCP Approval for 100% Acquisition of Pakheim International

CPHL Citi Pharma Ltd.
Rs. 62.18 -0.27%
Stock ImpactPositive

The Competition Commission of Pakistan (CCP) has approved the proposed acquisition of a 100% shareholding in Pakheim International Pharma (Private) Limited by Citi Pharma Limited (PSX: CPHL).

According to a filing with the Pakistan Stock Exchange, Citi Pharma received the CCP's authorization order dated October 9, 2026. The commission determined that the transaction raises no competition concerns in the market.

The acquisition will proceed under the Share Purchase Agreement dated May 6, 2026, subject to completing standard legal and regulatory formalities.

Read the full story on the original publisher’s website.

Open original article